# Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

> **NCT03318159** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Aplastic Anemia
- Myelodysplastic Syndromes
- Fungal Infection

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT03318159
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-07-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318159, "Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03318159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*